| Literature DB >> 34984451 |
Joshua M Hare1, Isabel Beerman2.
Abstract
While there is extensive interest in geroscience approaches to health and disease, few basic science discoveries have made their way into clinical trials. Herein, we comment on cell-based therapies, in which supplementing robust stem cell capacity to aged systems theoretically could lead to sustained improvement. This exciting approach has undergone translational development, and we highlight studies targeting a single system and others aimed at treating overall aging frailty by restoring the aged stem cell niches that underly diminished endogenous regenerative capacity. Published by Oxford University Press on behalf of The Gerontological Society of America 2022.Entities:
Keywords: Aging; Clinical trials; Intervention; Rejuvenation; Stem cells
Mesh:
Year: 2022 PMID: 34984451 PMCID: PMC9255684 DOI: 10.1093/gerona/glac003
Source DB: PubMed Journal: J Gerontol A Biol Sci Med Sci ISSN: 1079-5006 Impact factor: 6.591